Follow
About Douglas
Doug Gerlach is the senior equity analyst with Equity Research Service, a division of the National Association of Investors (NAIC), and editor-in-chief of its stock newsletters including the award-winning Investor Advisory Service, the market-beating SmallCap Informer, and a dividend-focused newsletter. NAIC is also the home of the BetterInvesting Stock Selection Guide and other tools for stock analysis including StockCentral.com and MyStockProspector.com. Mr. Gerlach is the author of six books, including Investment Clubs for Dummies and The Armchair Millionaire.
Douglas's Articles
With analysts looking for long-term EPS growth as high as 30% a year, Allient (ALNT) looks to offer a very attractive valuation if the company delivers on that expectation, explains Doug Gerlach, editor of SmallCap Informer.
Douglas Gerlach
INDUSTRIALS
Tickers: ALNT
Founded in 2002, Five Below (FIVE) is the leading high-growth value retailer marketing merchandise generally priced $5 or less to teens and tweens. The company also ends up selling to Generation Z’s parents. The average customer household income is approximately $75,000, with 14% having incomes over $100,000, recounts Doug Gerlach, editor of Investor Advisory Service.
Douglas Gerlach
CONSUMER
Tickers: FIVE
Long-term-focused advisors and analysts often counsel against attempting to “time the market,” rightly pointing out that no one has ever successfully been able to correctly call the market’s short-term directional changes with any accuracy. This is why I believe in bottom-up, long-term, buy-and- hold stock investing supported by sound portfolio diversification and management principles. One name I like is Fabrinet (FN), notes Douglas Gerlach, editor at Small Cap Informer.
Douglas Gerlach
TECHNOLOGY
Tickers: FN
Catalyst Pharmaceuticals (CPRX) is a commercial-stage biopharmaceutical company. It focuses on therapies for people with rare debilitating, chronic neuromuscular, and neurological and epileptic diseases. Catalyst invests in the acquisition of innovative rare neurological and epilepsy assets that align with its primary focus on conditions treated by neurologists and neuromuscular specialists, explains Douglas Gerlach, editor at Small Cap Informer.
Douglas Gerlach
STRATEGIES
Tickers: CPRX
Douglas's Videos
Stock investors often shy away from including gold and mining stocks in their portfolios. But is there a place for these kinds of companies in a growth- and quality-oriented portfolio? Doug Gerlach, editor-in-chief of the award-winning Investor Advisory Service and the SmallCap Informer stocknewsletters, has ideas to improve your portfolio diversification with gold mining stocks.
Douglas Gerlach
STOCKS
29:28
For long-term stock investors, mid-sized companies occupy a sweet spot. These companies have enough history to allow for analysis of management strength and plenty of time to continue on their growth trajectories, but still fly low enough to allow for buying at reasonable valuations. This is why the Investor Advisory Service newsletter--rated #1 for newsletter performance in 2021 by Hulbert Ratings--follows a healthy selection of mid-sized stocks. In this session, Doug Gerlach, editor-in-chief, will review the reasons why you should consider midsized companies and provide some of his team's best stock ideas for the current market.
Douglas Gerlach
STOCKS
32:43
The prospects of higher inflation, supply chain disruptions, increasing energy prices, rising interest rates, and slowing consumer spending will all impact American businesses in 2022. Companies in some sectors and industries might perform better than others, though, if they possess the right qualities. In this session, Doug Gerlach, editor of the SmallCap Informer and Investor Advisory Service stock newsletters, will share his team's thoughts on the characteristics that will allow some stocks to stand out in 2022.
Douglas Gerlach
STOCKS
34:48
Gold prices dropped in the first half of 2021 but concerns about inflation and capital preservation may be part of a collection of macro factors that could drive higher prices for the rest of the year. For stock investors not accustomed to including gold in their portfolio composition, there may be some opportunities to consider in gold miners and royalty stocks. In this session, Doug Gerlach will discuss some of his favorite gold miners from the perspective of fundamental, long-term focused investors, taken from his market-beating SmallCap Informer newsletter.
Douglas Gerlach
STOCKS
36:11
Douglas's Books
Douglas Gerlach
The Armchair Millionaire
Packed with practical advice, personalized tools such as user-friendly worksheets, and actual stories of ordinary people who have built extraordinary portfolios using these methods, The Armchair Millionaire will show you how to get on the road to
Douglas Gerlach
The Pocket Idiot's Guide to Direct Stock Investing: Take Charge of Your Portfolio
A profitable purchase for investment enthusiasts. 'The Pocket Idiot's Guide™ to Direct Stock Investing' reveals an innovative style of investment that has been steadily growing under the huge shadow of Wall-Street home investors opening a Direct Stock Purchase (DSP) or a Dividend Reinvestment Plan (DRIP) now offered by hundreds of major corporations, commission free. Investment guru Douglas Gerlach, an expert in
Newsletter Contributions
Investor Advisory Service
Each monthly issue of the Investor Advisory Service is packed with information aimed at helping you make smarter investing decisions about the stocks in your portfolio. From helping you gain perspective on the broader economic outlook, to identifying new stocks to consider, IAS will educate and inform you each month.
Learn More